Anti COVID-19 Drug Without Side Effects Being Developed in India: CDRI Medical Dialogues Bureau22 Jan 2022 11:05 AMCDRI director Prof Tapas Kundu said: "CDRI is working round-the-clock to develop drugs that can help in treating all variants of Covid-19, besides...
Breakthrough in COVID-19 treatment: Clinical trial for New drug Umifenovir shows promising results ROSHNI DHAR16 Sept 2021 4:15 PMLucknow: In a major breakthrough for COVID-19 treatment, the Central Drug Research Institute (CDRI) has claimed that its antiviral drug Umifenovir...
Antiviral drug Umifenovir proves successful in clinical trials for COVID MD Bureau16 Sept 2021 4:30 AMLucknow: The Central Drug Research Institute (CDRI) has claimed that the clinical trials of antiviral drug, Umifenovir, in treatment of Covid-19, have...
Test efficacy of umifenovir alone, not with favipiravir for COVID cure: CDSCO panel to Macleods Pharma Farhat Nasim17 Oct 2020 8:30 AMNew Delhi: Mumbai-based Macleods Pharma recently asked permission to test the influenza drug, Umifenovir Hydrochloride along with Favipiravir, as a...
Death During Glenmark Favipiravir-Umifenovir Trial: CDSCO seeks adverse event report Farhat Nasim15 Oct 2020 7:04 AMNew Delhi: The Mumbai-based drugmaker, Glenmark Pharmaceuticals Ltd., has been directed by the apex drug regulator, Central Drugs Standard Control...
Combining Umifenovir, Favipiravir for mild COVID treatment did not show benefit: Glenmark MD Bureau9 Oct 2020 3:35 PMThe addition of Umifenovir did not demonstrate any additional benefit over Favipiravir alone in moderate Covid-19 patients, Glenmark said.
CSIR gets DCGI nod for Phase III Clinical Trial of Umifenovir in COVID-19 Ruchika Sharma19 Jun 2020 5:43 AMUmifenovir is mainly used for the treatment of influenza and is available in China and Russia, and has recently come into prominence due to its...
Glenmark to Commence Another New Phase 3 Clinical Trial India testing on Combination of Favipiravir, Umifenovir Moderate COVID-19 hospitalised patients Ruchika Sharma26 May 2020 8:18 AMThe new combination clinical trial will be called FAITH - (Favipiravir plus Umifenovir (efficacy & safety) Trial in an Indian Hospital setting)
